SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-031481
Filing Date
2019-08-12
Accepted
2019-08-12 16:12:20
Documents
3
Period of Report
2019-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ngm-8k_20190812.htm 8-K 37604
2 EX-99.1 ngm-ex991_6.htm EX-99.1 234883
3 GRAPHIC gf2zpiaqwigm000001.jpg GRAPHIC 4434
  Complete submission text file 0001564590-19-031481.txt   279878
Mailing Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-243-5555
NGM BIOPHARMACEUTICALS INC (Filer) CIK: 0001426332 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38853 | Film No.: 191016649
SIC: 2834 Pharmaceutical Preparations